| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.5 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.5 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.052 | 0.5 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.18 | 0.5 |